WHO Reference # | Name | Applicant | Formulation |
---|---|---|---|
RH049 (a) | Desogestrel/Ethinyl Estradiol + Placebo | Mylan Labs LTD
|
DESOGESTREL: 150 μg ETHINYL ESTRADIOL: 30 μg Tablet Placebo tablet: 0 mg |
RH044 (a) | Desogestrel/Ethinyl Estradiol + Placebo | Lupin LTD
|
DESOGESTREL: 150 μg ETHINYL ESTRADIOL: 30 μg Tablet Placebo tablet: 0 mg |
RH042 (a) | Ethinyl Estradiol/Levonorgestrel + Placebo | Lupin LTD
|
ETHINYL ESTRADIOL: 0.03 mg LEVONORGESTREL: 0.15 mg Tablet Placebo tablet: 0 mg |
RH041 (a) | Ethinyl Estradiol/Levonorgestrel + Placebo | Lupin LTD
|
ETHINYL ESTRADIOL: 0.03 mg LEVONORGESTREL: 0.15 mg Tablet Placebo Tablet: 0 mg |
RH038 | Ethinyl Estradiol/Levonorgestrel + Ferrous Fumarate | Mylan Labs LTD
|
ETHINYL ESTRADIOL: 30 μg LEVONORGESTREL: 150 μg Tablet Placebo (Ferrous Fumarate Tablet): 75 mg |
RH037 (a) | Desogestrel/Ethinyl Estradiol | Mylan Labs LTD
|
DESOGESTREL: 0.150 mg ETHINYL ESTRADIOL: 0.030 mg Tablet |
RH035 | Ethinyl Estradiol/Levonorgestrel + Placebo | Mylan Labs LTD
|
ETHINYL ESTRADIOL: 30 μg LEVONORGESTREL: 150 μg Placebo: 0 mg Sugar-coated tablet |
RH030 | Ethinyl Estradiol/Levonorgestrel + Placebo | Cipla Ltd
|
ETHINYL ESTRADIOL: 0.03 mg LEVONORGESTREL: 0.150 mg Placebo Tablet: 0 mg Tablet |
RH025 (a) | Desogestrel/Ethinyl Estradiol + Placebo | NV Organon
|
DESOGESTREL: 0.150 mg ETHINYL ESTRADIOL: 0.030 mg Placebo: 0 mg Tablet |
RH013 | Ethinyl Estradiol/Levonorgestrel | Mylan Labs LTD
|
ETHINYL ESTRADIOL: 30 μg LEVONORGESTREL: 150 μg Sugar-coated tablet |
RH003 (a) | Ethinyl Estradiol/Levonorgestrel + Placebo | Jenapharm GmbH & Co. KG
|
ETHINYL ESTRADIOL: 150 μg LEVONORGESTREL: 30 μg Placebo (Ferrous Fumarate): 75 mg Film coated tablet |